ARK1

ARK1 (PF3D7_0605300) is an essential Aurora-related Ser/Thr kinase that serves as the principal mitotic Aurora kinase driving spindle biogenesis, kinetochore dynamics, chromosome segregation, and cytokinesis during Plasmodium proliferative and sexual stages (PMID:21166904, PMID:41748607, PMID:41041543, PMID:40909691). During P. falciparum erythrocytic schizogony it localizes as paired dots at duplicated spindle pole bodies and along the inner MTOC/mitotic spindle, with expression extending to male late-stage gametocytes consistent with a role in endomitotic male gametogenesis (PMID:21166904, PMID:39235260). ARK1 forms the catalytic core of a non-canonical chromosomal passenger complex built on two highly divergent inner centromere proteins, INCENP-A and INCENP-B, and lacking the canonical chromatin-targeting subunits Survivin and Borealin; conditional depletion disrupts spindle biogenesis, kinetochore segregation, karyokinesis, and cytokinesis in both schizogony and male gametogony and impairs transmission (PMID:41748607, PMID:41041543, PMID:40909691). In P. berghei, ARK1 localizes to spindle poles, spindles, and kinetochores, and its CPC composition is stage-modular — a minimal ARK1–INCENP-A complex during male gametogenesis expands during meiosis to include INCENP-B, centromeric histones, and spindle assembly checkpoint proteins — and its depletion produces short/multipolar spindles, kinetochore misalignment, and failed chromosome partitioning (PMID:42323312). ARK1 functions in the same pathway as the kinase PfNek1, with which it shows a genetic epistatic interaction, and is the specific target of the Aurora inhibitor hesperadin, whose activity manifests as unsegregated multi-lobed nuclei from aberrant microtubule organization (PMID:33219324, PMID:41131905).

1. 2010 Medium

   Establishing where ARK1 acts and whether it is dispensable was the first step; localizing it to duplicated spindle pole bodies at M-phase entry and failing to knock it out placed ARK1 at the mitotic machinery and marked it essential.

   Evidence Endogenous GFP-tagging with live imaging, anti-α-tubulin immunofluorescence, and attempted gene knockout in P. falciparum schizonts

   PMID:21166904

   Open questions at the time

   • Essentiality inferred from failed knockout rather than a conditional system
   • No molecular substrates or kinase activity demonstrated
   • No interacting partners identified
2. 2020 Medium

   To place ARK1 within a signaling pathway, resistance selection against the Aurora inhibitor hesperadin was used; recovery of PfNek1 mutations revealed an epistatic interaction, positioning ARK1 and PfNek1 in the same functional pathway.

   Evidence Drug-resistance selection, whole-genome sequencing of resistant P. falciparum mutants, and genetic epistasis analysis

   PMID:33219324

   Open questions at the time

   • Interaction is genetic/indirect, not a demonstrated physical or biochemical link
   • Directionality and mechanism of ARK1–PfNek1 pathway coupling unresolved
3. 2024 Medium

   Systematic imaging across the cell cycle and gametocyte stages refined ARK1's spatiotemporal deployment, associating it with centriolar plaque maturation, spindle assembly, and kinetochore-spindle attachment, and distinguishing it from sibling Aurora kinases.

   Evidence Transgenic GFP-tagging of endogenous loci and systematic fluorescence microscopy across schizogony and gametocyte stages in P. falciparum

   PMID:39235260

   Open questions at the time

   • Localization inferred function without depletion or rescue
   • Male-specific expression not tied to a defined gametogenesis phenotype at this stage
4. 2025 Medium

   Chemical and biochemical validation established ARK1 as the primary mitotic Aurora kinase by showing hesperadin specifically targets ARK1 and its inhibition blocks mitosis, producing unsegregated multi-lobed nuclei from aberrant microtubule organization.

   Evidence Hesperadin inhibition, whole-cell and protein kinase activity assays, and morphological phenotyping of drug-treated P. falciparum

   PMID:41131905

   Open questions at the time

   • Bifunctional Aurora A/B activity inferred rather than mapped to distinct substrates
   • Direct kinase substrates remain unidentified
5. 2025 Medium

   Conditional knockdown coupled with competitive binding implicated ARK1 in the antiparasitic mechanism of the Chk1 inhibitor CHIR-124, supporting ARK1 as a druggable target.

   Evidence Conditional ARK1 knockdown and competitive binding assays in P. falciparum (preprint, later peer-reviewed)

   PMID:40791395 PMID:42287204

   Open questions at the time

   • CHIR-124 binds several Plasmodium kinases, so ARK1's contribution to killing is not isolated
   • Structural basis of binding not defined
6. 2026 High

   Conditional depletion plus interactomics resolved ARK1's mechanism, defining it as the catalytic core of a non-canonical CPC with divergent INCENP-A/INCENP-B scaffolds lacking Survivin and Borealin, and showing its loss disrupts spindle biogenesis, kinetochore segregation, karyokinesis, cytokinesis, and transmission.

   Evidence Conditional ARK1 depletion, mass-spectrometry interactome, fluorescence microscopy, and comparative genomics in P. falciparum and P. berghei

   PMID:40909691 PMID:41041543 PMID:41748607

   Open questions at the time

   • How the non-canonical CPC is targeted to centromeres without Survivin/Borealin is unresolved
   • Phosphorylation substrates of the ARK1 CPC not mapped
7. 2026 High

   In P. berghei, depletion and stage-resolved interactomics established that the ARK1 CPC is modular, a minimal ARK1–INCENP-A unit in male gametogenesis expanding during meiosis to include INCENP-B, centromeric histones, and spindle assembly checkpoint proteins, linking composition to faithful chromosome inheritance.

   Evidence Conditional ARK1 depletion, fluorescence and live-cell imaging, and mass-spectrometry interactome across gametogenesis and meiosis in P. berghei

   PMID:42323312

   Open questions at the time

   • Trigger and regulation of stage-specific CPC remodeling unknown
   • Functional consequence of each added meiotic component not individually dissected

• How the ARK1 CPC is recruited to centromeres in the absence of canonical chromatin-targeting subunits, and which substrates it phosphorylates to drive kinetochore and spindle function, remain unresolved.
• No ARK1 phosphorylation substrates identified
• Chromatin-targeting mechanism of the Survivin/Borealin-lacking CPC unknown
• Structural basis of the ARK1–INCENP-A/B interaction not determined